April showers bring more biotechs to Nasdaq, as Rain and Impel bump 2021’s total raise above $6B

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.

What’s that in the sky — is it a bird? Is it a plane? No, it’s another handful of biotech IPOs.

Two more biotechs priced their public offerings late Thursday, coming just one…